Natixis Bleichroeder Starts Quest Diagnostics (DGX) at Buy
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $236.59 +1.54%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 13 | New: 70
Join SI Premium – FREE
Natixis Bleichroeder initiates coverage on Quest Diagnostics (NYSE: DGX) with a Buy. PT $59.00.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $50.36 yesterday.
For more ratings news on Quest Diagnostics click here and for the rating history of Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $50.36 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Starts Eupraxia Pharmaceuticals (EPRX) at Outperform
- Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026
- Wells Fargo Starts 3M (MMM) at Equal Weight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Natixis BleichroederSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
